Universe Pharmaceuticals (UPC) Retained Earnings (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Retained Earnings data on file, last reported at -$1.8 billion in Q3 2025.

• For the quarter ending Q3 2025, Retained Earnings rose 82.17% year-over-year to -$1.8 billion; the trailing twelve-month figure through Sep 2025 stood at -$1.8 billion (up 82.17% YoY), and the FY2025 full-year result was -$1.8 billion, up 82.17% from the prior year.
• Retained Earnings grew to -$1.8 billion in Q3 2025, from -$10.2 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $29.3 million in Q1 2022 to a low of -$10.2 billion in Q3 2024.
• A 5-year average of -$1.5 billion and a median of -$1.6 million in 2022 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings slumped 704170.53% in 2024 and soared 82.17% in 2025, its largest moves.
• Tracing UPC's Retained Earnings over 5 years: stood at $25.1 million in 2021, then sank by 106.65% to -$1.7 million in 2022, then increased by 13.35% to -$1.4 million in 2023, then tumbled by 704170.53% to -$10.2 billion in 2024, then soared by 82.17% to -$1.8 billion in 2025.
• Business Quant data shows UPC's Retained Earnings at -$1.8 billion in Q3 2025, -$10.2 billion in Q3 2024, and -$2.1 million in Q1 2024.